178 related articles for article (PubMed ID: 34590009)
1. Ki67 (MIB-1) as a Prognostic Marker for Clinical Decision Making Before Extended Pleurectomy Decortication in Malignant Pleural Mesothelioma.
Belderbos RA; Maat APWM; Baart SJ; Madsen EVE; Bogers AJJC; Cornelissen R; Aerts JGJV; Mahtab EAF; von der Thüsen JH
JTO Clin Res Rep; 2021 Apr; 2(4):100155. PubMed ID: 34590009
[TBL] [Abstract][Full Text] [Related]
2. Lymphangitic carcinomatosis: A common radiographic manifestation of local failure following extended pleurectomy/decortication in patients with malignant pleural mesothelioma.
Berger I; Cengel KA; Simone CB; Alley EW; Roshkovan L; Haas AR; Patel AM; Khalid U; Culligan MJ; McNulty S; Singhal S; Friedberg JS; Katz SI
Lung Cancer; 2019 Jun; 132():94-98. PubMed ID: 31097101
[TBL] [Abstract][Full Text] [Related]
3. A randomized phase II study of pleurectomy/decortication preceded or followed by (neo-)adjuvant chemotherapy in patients with early stage malignant pleural mesothelioma (EORTC 1205).
Raskin J; Surmont V; Cornelissen R; Baas P; van Schil PEY; van Meerbeeck JP
Transl Lung Cancer Res; 2018 Oct; 7(5):593-598. PubMed ID: 30450298
[TBL] [Abstract][Full Text] [Related]
4. Radical pleurectomy/decortication followed by high dose of radiation therapy for malignant pleural mesothelioma. Final results with long-term follow-up.
Minatel E; Trovo M; Polesel J; Baresic T; Bearz A; Franchin G; Gobitti C; Rumeileh IA; Drigo A; Fontana P; Pagan V; Trovo MG
Lung Cancer; 2014 Jan; 83(1):78-82. PubMed ID: 24216141
[TBL] [Abstract][Full Text] [Related]
5. Induction Chemotherapy Followed by Pleurectomy Decortication and Hyperthermic Intraoperative Chemotherapy (HITHOC) for Early-Stage Epitheliod Malignant Pleural Mesothelioma-A Prospective Report.
Bongiolatti S; Mazzoni F; Salimbene O; Caliman E; Ammatuna C; Comin CE; Antonuzzo L; Voltolini L
J Clin Med; 2021 Nov; 10(23):. PubMed ID: 34884251
[TBL] [Abstract][Full Text] [Related]
6. Pleurectomy-decortication in malignant pleural mesothelioma: are different surgical techniques associated with different outcomes? Results from a multicentre study.
Marulli G; Breda C; Fontana P; Ratto GB; Leoncini G; Alloisio M; Infante M; Luzzi L; Paladini P; Oliaro A; Ruffini E; Benvenuti MR; Pariscenti G; Spaggiari L; Casiraghi M; Rusca M; Carbognani P; Ampollini L; Facciolo F; Leuzzi G; Mucilli F; Camplese P; Romanello P; Perissinotto E; Rea F
Eur J Cardiothorac Surg; 2017 Jul; 52(1):63-69. PubMed ID: 28419212
[TBL] [Abstract][Full Text] [Related]
7. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.
Flores RM; Pass HI; Seshan VE; Dycoco J; Zakowski M; Carbone M; Bains MS; Rusch VW
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):620-6, 626.e1-3. PubMed ID: 18329481
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Intraoperative Hypertonic Glucose Solution Administration on Persistent Air Leak After Extended Pleurectomy/Decortication for Malignant Pleural Mesothelioma: A Retrospective Case-Control Study.
Testori A; Perroni G; Alloisio M; Voulaz E; Giudici VM; Cariboni U; Bottoni E
Front Oncol; 2021; 11():767791. PubMed ID: 34926272
[TBL] [Abstract][Full Text] [Related]
9. Non-incisional pleurectomy/decortication for malignant pleural mesothelioma.
Tanaka F; Takenaka M; Imanishi N; Hirai A; Kanayama M; Mori M; Matsumiya H; Taira A; Shinohara S; Kuroda K
Gen Thorac Cardiovasc Surg; 2021 Sep; 69(9):1320-1325. PubMed ID: 34028663
[TBL] [Abstract][Full Text] [Related]
10. Extended Pleurectomy and Decortication for Malignant Pleural Mesothelioma Is an Effective and Safe Cytoreductive Surgery in the Elderly.
Williams T; Duraid H; Watson S; Durkin A; Todd K; Kindler HL; Vigneswaran WT
Ann Thorac Surg; 2015 Nov; 100(5):1868-74. PubMed ID: 26319490
[TBL] [Abstract][Full Text] [Related]
11. Mesothelioma and Radical Surgery 2 (MARS 2): protocol for a multicentre randomised trial comparing (extended) pleurectomy decortication versus no (extended) pleurectomy decortication for patients with malignant pleural mesothelioma.
Lim E; Darlison L; Edwards J; Elliott D; Fennell DA; Popat S; Rintoul RC; Waller D; Ali C; Bille A; Fuller L; Ionescu A; Keni M; Kirk A; Koh P; Lau K; Mansy T; Maskell NA; Milton R; Muthukumar D; Pope T; Roy A; Shah R; Shamash J; Tasigiannopoulos Z; Taylor P; Treece S; Ashton K; Harris R; Joyce K; Warnes B; Mills N; Stokes EA; Rogers C;
BMJ Open; 2020 Sep; 10(9):e038892. PubMed ID: 32873681
[TBL] [Abstract][Full Text] [Related]
12. High dose irradiation after pleurectomy/decortication or biopsy for pleural mesothelioma treatment.
Parisi E; Romeo A; Sarnelli A; Ghigi G; Bellia SR; Neri E; Micheletti S; Dipalma B; Arpa D; Furini G; Burgio MA; Genestreti G; Gurioli C; Sanna S; Bovolato P; Rea F; Storme G; Scarpi E; Arienti C; Tesei A; Polico R
Cancer Radiother; 2017 Dec; 21(8):766-773. PubMed ID: 29132803
[TBL] [Abstract][Full Text] [Related]
13. Extended pleurectomy/decortication and hyperthermic intraoperative intrapleural cisplatin perfusion for malignant pleural mesothelioma.
Okubo K; Ishibashi H; Wakejima R; Baba S; Asakawa A; Seshima H
JTCVS Open; 2023 Dec; 16():977-986. PubMed ID: 38204668
[TBL] [Abstract][Full Text] [Related]
14. Extended pleurectomy decortication for malignant pleural mesothelioma in the elderly: the need for an inclusive yet selective approach.
Sharkey AJ; Bilancia R; Tenconi S; Nakas A; Waller DA
Interact Cardiovasc Thorac Surg; 2017 Nov; 25(5):696-702. PubMed ID: 29049744
[TBL] [Abstract][Full Text] [Related]
15. Prolonged post-recurrence survival following pleurectomy/decortication for malignant pleural mesothelioma.
Kai Y; Tsutani Y; Tsubokawa N; Ito M; Mimura T; Miyata Y; Okada M
Oncol Lett; 2019 Mar; 17(3):3607-3614. PubMed ID: 30867804
[TBL] [Abstract][Full Text] [Related]
16. Improved Outcomes with Modern Lung-Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma.
Shaikh F; Zauderer MG; von Reibnitz D; Wu AJ; Yorke ED; Foster A; Shi W; Zhang Z; Adusumilli PS; Rosenzweig KE; Krug LM; Rusch VW; Rimner A
J Thorac Oncol; 2017 Jun; 12(6):993-1000. PubMed ID: 28341225
[TBL] [Abstract][Full Text] [Related]
17. Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study.
Ghanim B; Klikovits T; Hoda MA; Lang G; Szirtes I; Setinek U; Rozsas A; Renyi-Vamos F; Laszlo V; Grusch M; Filipits M; Scheed A; Jakopovic M; Samarzija M; Brcic L; Stancic-Rokotov D; Kern I; Rozman A; Dekan G; Klepetko W; Berger W; Glasz T; Dome B; Hegedus B
Br J Cancer; 2015 Mar; 112(5):783-92. PubMed ID: 25633038
[TBL] [Abstract][Full Text] [Related]
18. Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients.
Borasio P; Berruti A; Billé A; Lausi P; Levra MG; Giardino R; Ardissone F
Eur J Cardiothorac Surg; 2008 Feb; 33(2):307-13. PubMed ID: 18164622
[TBL] [Abstract][Full Text] [Related]
19. Extended Pleurectomy/Decortication for Malignant Pleural Mesothelioma: Humanitas's Experience.
Mangiameli G; Bottoni E; Voulaz E; Cariboni U; Testori A; Crepaldi A; Giudici VM; Morenghi E; Alloisio M
J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768488
[TBL] [Abstract][Full Text] [Related]
20. Pleurectomy/decortication and hyperthermic intrathoracic chemoperfusion using cisplatin and doxorubicin for malignant pleural mesothelioma.
Klotz LV; Lindner M; Eichhorn ME; Grützner U; Koch I; Winter H; Kauke T; Duell T; Hatz RA
J Thorac Dis; 2019 May; 11(5):1963-1972. PubMed ID: 31285889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
